Effect of Zoledronic Acid as Anti-Cancer Treatment in Metastatic Breast Cancer Patients
Status:
Completed
Trial end date:
2012-08-01
Target enrollment:
Participant gender:
Summary
This study will evaluate zoledronic acid's anti-cancer effects and Circulating Tumor Cell
(CTCs) measurements in patients with HER2-negative metastatic breast cancer without bone
metastasis.